Tags

Type your tag names separated by a space and hit enter

Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.
Am J Ther. 2021 07 05; 28(5):e592-e596.AJ

Authors+Show Affiliations

Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA.Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA.Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA.Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA.Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA.Department of Infectious Diseases, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA.

Pub Type(s)

Letter

Language

eng

PubMed ID

34264890

Citation

Morin, Scott J., et al. "Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients." American Journal of Therapeutics, vol. 28, no. 5, 2021, pp. e592-e596.
Morin SJ, Jani C, Rupal A, et al. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients. Am J Ther. 2021;28(5):e592-e596.
Morin, S. J., Jani, C., Rupal, A., Singh, H., Bourque, D., & Colgrove, R. C. (2021). Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients. American Journal of Therapeutics, 28(5), e592-e596. https://doi.org/10.1097/MJT.0000000000001412
Morin SJ, et al. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients. Am J Ther. 2021 07 5;28(5):e592-e596. PubMed PMID: 34264890.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients. AU - Morin,Scott J, AU - Jani,Chinmay, AU - Rupal,Arashdeep, AU - Singh,Harpreet, AU - Bourque,Daniel, AU - Colgrove,Robert C, Y1 - 2021/07/05/ PY - 2021/7/16/pubmed PY - 2021/7/16/medline PY - 2021/7/15/entrez SP - e592 EP - e596 JF - American journal of therapeutics JO - Am J Ther VL - 28 IS - 5 SN - 1536-3686 UR - https://www.unboundmedicine.com/medline/citation/34264890/Tocilizumab_Induces_Rapid,_Sustained_Improvement_of_Inflammatory_Markers_in_COVID-19,_With_Clinical_Improvement_in_Most_Patients. L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=34264890.ui DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.